Skip to content

Efficacy and safety of mesotherapy combined with intense pulsed light, mesotherapye, intense pulsed light in the treatment of post-acne erythema

Efficacy and safety of mesotherapy combined with intense pulsed light, mesotherapye, intense pulsed light in the treatment of post-acne erythema

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075561
Enrollment
Unknown
Registered
2023-09-08
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-acne erythema

Interventions

Mesotherapy combined with IPL group:Mesotherapy combined with Intense Pulsed Light
Mesotherapy group:Mesotherapy
Blank control group:None

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: 1.Patients who are diagnosed with persistent PAE=3 months and suffer from symmetrical facial rashes. 2.Aged >=18 years, < 60 years.

Exclusion criteria

Exclusion criteria: 1.Patients with a history of facial laser treatment, chemical peeling or filling treatment within 1 year; 2.Patients who systematically used retinoids within 6 months, or tetracyclines or 4-quinolones within a month; 3. Patients whose face were suntanned due to sunlight within a month; 4. Patients with a history of facial skin cancer or facial skin disease which can be aggravated by light exposure; 5. Patients with scar constitution or active skin disease prone to Koebner phenomenon; 6. Pregnant or lactating patients; 7. Patients with serious internal diseases involving circulatory system, respiratory system, urinary system, digestive system or endocrine system; 8. Patients with a history of mental illness; 9. Allergic to the testing drug and its components; 10.The researcher thinks that it is not suitable to participate in this research.

Design outcomes

Primary

MeasureTime frame
Clinician Erythema Assessment Scale;

Secondary

MeasureTime frame
Global Aesthetic Improvement Scale;Patient-self assessment;Dermatology Life Quality Index;The erythroid value of VISIA Imaging;Skin Barrier Index Detection;

Countries

China

Contacts

Public ContactZhuo Fenglin

Beijing Friendship Hospital, Capital Medical University

zflsunny@hotmail.com+86 159 1089 5068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026